Polymer-ritonavir derivate nanomedicine with pH-sensitive activation possesses potent anti-tumor activity in vivo via inhibition of proteasome and STAT3 signaling

Calreticulin exposure dictates the immunogenicity of cancer cell death

Michel Obéid, Antoine Tesnière, François Ghiringhelli et al. · Nature Medicine · 2006 · 3K citations

Cancer Immunosurveillance, Calreticulin Exposure, Immunotoxicology +6

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Noëlia Casares, Marie O. Péquignot, Antoine Tesnière et al. · The Journal of Experimental Medicine · 2005 · 1.4K citations · Full text

Immunology, Immunoediting, Cell Death +16

CD4 ⁺ Regulatory T Cells Control T _H 17 Responses in a Stat3-Dependent Manner

Ashutosh Chaudhry, Dipayan Rudra, Piper M. Treuting et al. · Science · 2009 · 971 citations · Full text

T-regulatory Cell, Immunology, Immune Regulation +19

Semi-quantitative Determination of Protein Expression Using Immunohistochemistry Staining and Analysis: An Integrated Protocol

Alexandra Crowe, Wei Yue · BIO-PROTOCOL · 2019 · 738 citations · Full text

Immunocytochemical Technique, Immunology, Imagej Fiji +22

Phase I clinical and pharmacokinetic study of PK1 [N-(2-hydroxypropyl)methacrylamide copolymer doxorubicin]: first member of a new class of chemotherapeutic agents-drug-polymer conjugates. Cancer Research Campaign Phase I/II Committee.

P. Vasey, Stan B. Kaye, Rachel Morrison et al. · PubMed · 1999 · 691 citations

Pathology, Pharmacotherapy, Maximum Tolerated Dose +16